Luna Diabetes
CA - San DiegoBiotechnology
Focus: Luna Diabetes is a biotechnology company developing innovative insulin delivery systems, specifically focused on an episodic overnight patch pump for Type 1 Diabetes. The company is early-stage with minimal public financial data and a small active headcount.
Profile data last refreshed 2h ago · AI intelligence enriched 1w ago
Open Jobs
2
Should You Work at Luna Diabetes?
AI assessmentLuna Diabetes is a high-risk, high-reward early-stage bet best suited for entrepreneurial candidates comfortable with regulatory uncertainty and seeking equity upside in a specialized insulin device niche.
Why Work Here
- Early-stage medtech opportunity with focused pipeline in high-need diabetes segment—potential for outsized equity upside if device gains regulatory traction
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Episodic overnight patch pump
Type 1 Diabetes MellitusClinical Trials (1)
NCT06627517Safety and Effectiveness of the Luna System in People With Type 1 Diabetes Mellitus
N/AHelp build intelligence for Luna Diabetes
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.